Advertisement

cancer talk

  • 0 Comments

    Considering the Term “Cancer Survivor”

    A study investigates how people who have been diagnosed with cancer feel about being called survivors.

    by Jen Tota McGivney

  • 0 Comments

    Making Clinical Trials More Inclusive

    Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.

    by Ashley P. Taylor

  • 0 Comments

    What Do Clinical Trial Endpoints Really Measure?

    A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.

    by Jon Kelvey

  • 0 Comments

    Shingles Risk Increased for Cancer Patients

    A new vaccine is safe for cancer patients but hard to find.

    by Nancy Averett

  • 0 Comments

    Treating Breast Cancer in Men

    Hormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women.

    by Marilyn Fenichel

  • 0 Comments

    Combining Treatment With Hospice Services

    Organizations are testing new models of end-of-life care that allow patients to start hospice without stopping treatment.

    by Cheryl Platzman Weinstock

  • 0 Comments

    2018: This Year in Cancer News

    The Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.

    by Cancer Today Staff

  • 0 Comments

    The Education of a Patient Advocate

    Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.

    by Bob Riter

  • 0 Comments

    Caregivers Need Support Too

    High-intensity cancer caregiving is associated with poor mental health, especially for caregivers who don’t feel they’re getting the support services they need.

    by Jen Tota McGivney

  • 0 Comments

    2018 SABCS: Choosing the Right Treatment

    Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.

    by Kate Yandell

Advertisement

From the AACR

Advertisement

Video

Bob Riter: The Bridge Builder

Advertisement

social media

donate to the AACR